GLP-1 drugs: what Mississippi Medicaid paid

Q: Does a paid prescription mean Mississippi Medicaid covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Q: Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

Q: What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.

Mississippi Medicaid shows a published payment figure for 8 of the 8 GLP-1 products this site tracks, in the latest federal quarter. This site has not yet read Mississippi Medicaid's own coverage rule, so the figures below are a payment history and nothing here tells you what the program will decide next.

By the Covered Weight editorial team · Updated Aug 8, 2026. Research and sourcing by Evan Reid.

What Mississippi Medicaid’s payment record shows

In 2026Q1, the product Mississippi Medicaid paid for most often was Wegovy®, at 10,177 prescriptions¹³ of the 12,195 to 12,447^{1,7,13,19,25,31,37,43} across all 8 products, or 84 percent of the published count.

Mississippi Medicaid itself reimbursed at least $15,252,851 for these products in the quarter, about $1,254 per prescription. Pharmacies were paid $15,284,377 in total, the difference being what other payers covered on the same claims. The costliest per prescription was Wegovy®, at about $1,310.

Every dollar figure on this page is what pharmacies were paid, before rebates. Manufacturers pay Medicaid programs rebates on these products, the federal file states that its amounts are not reduced by them, and CMS publishes no rebate figure per drug. So what Mississippi Medicaid finally kept is lower than what is shown here, by an amount this site cannot source.

Paid prescriptions per quarter, Mississippi Medicaid. The line is what the federal file published and the axis starts at zero. The shaded band is what the file leaves possible above it: each withheld product code stands for between one and ten prescriptions, so a wide band means a heavily suppressed record rather than a busy one. A gap in the line is a quarter the file did not report, never a zero.

What Mississippi Medicaid paid, product by product

For what each product is approved to treat, the split that decides most coverage questions, compare the products themselves.

Route, prescriptions, what Mississippi Medicaid paid and what all payers paid, for each GLP-1 product, 2026Q1
Product	Paid through	Prescriptions	Shareof this program	Program paidbefore rebates	All payers	Program per Rx
tirzepatideZepbound®	Managed care	at least 176¹	1%	$187,738	$187,738	$1,067
tirzepatideMounjaro®	Both681 managed care, 66 direct	at least 747⁷	6%	$802,618	$808,763	$1,074
semaglutideWegovy®	Both9,170 managed care, 1,007 direct	at least 10,177¹³	84%	$13,332,024	$13,351,354	$1,310
semaglutideOzempic®	Both551 managed care, 27 direct	at least 578¹⁹	5%	$581,584	$587,635	$1,006
semaglutideRybelsus®	Managed care	at least 17²⁵	<1%	$17,049	$17,049	$1,003
liraglutideSaxenda®	Both	at least 64³¹	<1%	$71,190	$71,190	$1,112
liraglutideVictoza®	Both313 managed care, 67 direct	380³⁷	3%	$243,179	$243,179	$640
liraglutideliraglutide (generic)	Managed care	at least 28⁴³	<1%	$17,468	$17,468	$624

Mississippi Medicaid publishes claims on both routes: paid directly by the program, and paid through the managed-care plans it contracts with. The figures above combine the two, so which one your own card names decides who answers a question about your prescription.

Across the 21 quarters on file, prescriptions for the products published at both ends of the series were lower in 2026Q1 than in 2021Q1: 380 against 2,353. Products whose count was withheld at either end are left out of that comparison, because a floor against a number cannot establish a direction.

Against enrollment, that is 24.0 to 24.5 prescriptions per thousand people enrolled in Mississippi Medicaid, on an average of 508,725 enrollees across the quarter. A raw count compares programs by how many people they cover; this is the figure that compares them by what they paid for.

2026Q1 covers January through March 2026, and it is the newest quarter CMS has published; that file was released on July 10, 2026. Every count here is a prescription filled rather than a person: one patient on a monthly product contributes several in a quarter, so nothing on this page says how many people take these products.

The file withheld 9 of the 168 product-quarters it holds a row for here, which is 5 percent. Each withheld cell records prescriptions that were paid for and a count that is not disclosed, so any total on this page that includes one is a floor rather than a sum.

Ozempic® and Victoza® carry a published count in every one of the 21 quarters, which is the closest this record comes to showing a product paid for routinely.

21 quarters, 2021Q1 to 2026Q1

One quarter cannot tell you whether Mississippi Medicaid pays for a product routinely or barely at all, and a single withheld cell reads as an absence when it is not.

Show what Mississippi Medicaid paid for each product, quarter by quarter

Prescriptions Mississippi Medicaid paid for, by product and quarter, 2021Q1 to 2026Q1
Product	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1
tirzepatideZepbound®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2024Q3)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2024Q4)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2025Q1)the dataset publishes no row for this product, state and quarter²No row	withheld as a small cell paid prescriptions in the quarter (2025Q2)every reporting cell was withheld, so nothing is observable²Withheld7 of 7 product codes withheld	at least 50 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²At least$53,073 paid	at least 124 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²At least$131,689 paid	at least 176 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹At least$187,738 paid
tirzepatideMounjaro®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter¹¹No row	withheld as a small cell paid prescriptions in the quarter (2022Q2)every reporting cell was withheld, so nothing is observable¹¹Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q3)every reporting cell was withheld, so nothing is observable¹¹Withheld4 of 4 product codes withheld	at least 18 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld¹¹At least$16,960 paid	at least 87 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld¹⁰At least$86,049 paid	at least 189 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld¹⁰At least$183,629 paid	at least 267 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld¹⁰At least$252,343 paid	at least 295 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld¹⁰At least$285,425 paid	at least 316 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld⁹At least$304,863 paid	at least 423 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld⁹At least$414,036 paid	at least 415 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld⁹At least$428,510 paid	at least 429 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld⁹At least$442,144 paid	at least 427 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld⁸At least$442,698 paid	at least 511 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁸At least$531,509 paid	at least 619 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁸At least$647,127 paid	at least 700 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁸At least$733,959 paid	at least 747 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld⁷At least$802,618 paid
semaglutideWegovy®range 810 to 8,590	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter¹⁷No row	withheld as a small cell paid prescriptions in the quarter (2022Q3)every reporting cell was withheld, so nothing is observable¹⁷Withheld2 of 2 product codes withheld	at least 12 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld¹⁷At least$14,891 paid	at least 136 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld¹⁶At least$194,410 paid	withheld as a small cell paid prescriptions in the quarter (2023Q2)every reporting cell was withheld, so nothing is observable¹⁶Withheld5 of 5 product codes withheld	at least 339 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld¹⁶At least$440,763 paid	810 paid prescriptions in the quarter (2023Q4)¹⁶Count$1,048,666 paid	1,556 paid prescriptions in the quarter (2024Q1)¹⁵Count$1,999,616 paid	2,801 paid prescriptions in the quarter (2024Q2)¹⁵Count$3,610,922 paid	4,086 paid prescriptions in the quarter (2024Q3)¹⁵Count$5,319,646 paid	4,780 paid prescriptions in the quarter (2024Q4)¹⁵Count$6,226,404 paid	5,822 paid prescriptions in the quarter (2025Q1)¹⁴Count$7,584,852 paid	7,704 paid prescriptions in the quarter (2025Q2)¹⁴Count$10,035,344 paid	8,590 paid prescriptions in the quarter (2025Q3)¹⁴Count$11,234,929 paid	at least 9,669 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld¹⁴At least$12,676,825 paid	at least 10,177 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹³At least$13,332,024 paid
semaglutideOzempic®range 322 to 395	at least 143 paid prescriptions in the quarter (2021Q1)a floor, because some reporting cells were withheld²⁴At least$111,047 paid	at least 189 paid prescriptions in the quarter (2021Q2)a floor, because some reporting cells were withheld²⁴At least$149,842 paid	at least 264 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld²⁴At least$211,169 paid	322 paid prescriptions in the quarter (2021Q4)²⁴Count$262,583 paid	395 paid prescriptions in the quarter (2022Q1)²³Count$342,364 paid	at least 468 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²³At least$400,371 paid	at least 553 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²³At least$476,533 paid	at least 519 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²³At least$452,328 paid	at least 549 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²²At least$497,247 paid	at least 668 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²²At least$604,889 paid	at least 659 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²²At least$575,346 paid	at least 590 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²²At least$532,599 paid	at least 644 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld²¹At least$592,243 paid	at least 835 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld²¹At least$759,743 paid	at least 706 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld²¹At least$678,960 paid	at least 652 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld²¹At least$626,040 paid	at least 636 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²⁰At least$623,367 paid	at least 619 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²⁰At least$609,586 paid	at least 626 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²⁰At least$620,478 paid	at least 610 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²⁰At least$610,337 paid	at least 578 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹⁹At least$581,584 paid
semaglutideRybelsus®	withheld as a small cell paid prescriptions in the quarter (2021Q1)every reporting cell was withheld, so nothing is observable³⁰Withheld3 of 3 product codes withheld	at least 15 paid prescriptions in the quarter (2021Q2)a floor, because some reporting cells were withheld³⁰At least$11,936 paid	at least 29 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld³⁰At least$24,738 paid	at least 36 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld³⁰At least$33,048 paid	at least 31 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²⁹At least$27,185 paid	at least 52 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²⁹At least$60,458 paid	at least 49 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²⁹At least$50,124 paid	at least 49 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²⁹At least$44,984 paid	at least 42 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²⁸At least$39,800 paid	at least 41 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²⁸At least$42,697 paid	at least 40 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²⁸At least$40,150 paid	at least 43 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²⁸At least$46,428 paid	at least 33 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld²⁷At least$37,537 paid	at least 58 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld²⁷At least$60,744 paid	at least 47 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld²⁷At least$47,268 paid	at least 39 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld²⁷At least$38,707 paid	at least 40 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²⁶At least$39,731 paid	at least 24 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²⁶At least$23,404 paid	at least 36 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²⁶At least$35,168 paid	at least 29 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²⁶At least$28,339 paid	at least 17 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld²⁵At least$17,049 paid
liraglutideSaxenda®range 26 to 189	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter³⁶No row	withheld as a small cell paid prescriptions in the quarter (2021Q4)every reporting cell was withheld, so nothing is observable³⁶Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter³⁵No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter³⁵No row	withheld as a small cell paid prescriptions in the quarter (2022Q3)every reporting cell was withheld, so nothing is observable³⁵Withheld2 of 2 product codes withheld	26 paid prescriptions in the quarter (2022Q4)³⁵Count$31,830 paid	26 paid prescriptions in the quarter (2023Q1)³⁴Count$32,053 paid	withheld as a small cell paid prescriptions in the quarter (2023Q2)every reporting cell was withheld, so nothing is observable³⁴Withheld1 of 1 product codes withheld	189 paid prescriptions in the quarter (2023Q3)³⁴Count$210,117 paid	139 paid prescriptions in the quarter (2023Q4)³⁴Count$155,760 paid	at least 51 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld³³At least$40,809 paid	at least 70 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld³³At least$65,600 paid	at least 57 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld³³At least$55,199 paid	at least 52 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld³³At least$58,828 paid	at least 62 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld³²At least$70,187 paid	at least 58 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld³²At least$69,099 paid	87 paid prescriptions in the quarter (2025Q3)³²Count$95,686 paid	at least 68 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld³²At least$73,967 paid	at least 64 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld³¹At least$71,190 paid
liraglutideVictoza®range 291 to 3,748, up 54 on the quarter before	2,353 paid prescriptions in the quarter (2021Q1)⁴²Count$1,926,390 paid	2,806 paid prescriptions in the quarter (2021Q2)⁴²Count$2,308,360 paid	2,337 paid prescriptions in the quarter (2021Q3)⁴²Count$1,819,534 paid	3,115 paid prescriptions in the quarter (2021Q4)⁴²Count$2,521,593 paid	3,154 paid prescriptions in the quarter (2022Q1)⁴¹Count$2,641,879 paid	3,361 paid prescriptions in the quarter (2022Q2)⁴¹Count$2,816,373 paid	3,748 paid prescriptions in the quarter (2022Q3)⁴¹Count$3,217,615 paid	3,353 paid prescriptions in the quarter (2022Q4)⁴¹Count$2,776,419 paid	3,359 paid prescriptions in the quarter (2023Q1)⁴⁰Count$2,936,698 paid	3,239 paid prescriptions in the quarter (2023Q2)⁴⁰Count$2,864,628 paid	2,544 paid prescriptions in the quarter (2023Q3)⁴⁰Count$2,228,343 paid	2,125 paid prescriptions in the quarter (2023Q4)⁴⁰Count$1,866,364 paid	1,718 paid prescriptions in the quarter (2024Q1)³⁹Count$1,161,140 paid	1,419 paid prescriptions in the quarter (2024Q2)³⁹Count$912,996 paid	1,113 paid prescriptions in the quarter (2024Q3)³⁹Count$748,210 paid	923 paid prescriptions in the quarter (2024Q4)³⁹Count$635,231 paid	565 paid prescriptions in the quarter (2025Q1)³⁸Count$353,955 paid	294 paid prescriptions in the quarter (2025Q2)³⁸Count$194,426 paid	291 paid prescriptions in the quarter (2025Q3)³⁸Count$187,463 paid	326 paid prescriptions in the quarter (2025Q4)³⁸Count$204,332 paid	380 paid prescriptions in the quarter (2026Q1)³⁷Count$243,179 paid
liraglutideliraglutide (generic)	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter⁴⁵No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter⁴⁵No row	at least 70 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld⁴⁵At least$48,007 paid	at least 22 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld⁴⁵At least$18,767 paid	at least 45 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld⁴⁴At least$29,866 paid	at least 85 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁴⁴At least$48,748 paid	at least 96 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁴⁴At least$45,932 paid	at least 74 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁴⁴At least$45,536 paid	at least 28 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld⁴³At least$17,468 paid

What this page cannot tell you

Whether Mississippi Medicaid covers these products is decided by a document this site has not read yet: its preferred drug list and the prior-authorization criteria behind it. Until that is read and quoted, the payment history above is all this page asserts. Start from the notice or the drug list the program sent you, and check which document governs your plan first, because no state rule reaches a self-funded employer plan at all.

Open Mississippi in the coverage explorer to see all 21 quarters of trend per product and switch jurisdictions without leaving the table.

Compare another jurisdiction from the national comparison.

Documents this page reads

48 documents, cited by number above. Each opens to its section, its effective date, and the quote the fact came from.

SDUD 2026, Zepbound, MS
State Drug Utilization Data 2026, Datastore query result, product_name like ZEPBOUND%, state MS, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "MS", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "44"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Zepbound, MS
State Drug Utilization Data 2025, Datastore query result, product_name like ZEPBOUND%, state MS, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MS", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "40"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Zepbound, MS
State Drug Utilization Data 2024, Datastore query result, product_name like ZEPBOUND%, state MS, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MS", "product_name": "product_name like ZEPBOUND%, state MS, 2024", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Zepbound, MS
State Drug Utilization Data 2023, Datastore query result, product_name like ZEPBOUND%, state MS, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MS", "product_name": "product_name like ZEPBOUND%, state MS, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Zepbound, MS
State Drug Utilization Data 2022, Datastore query result, product_name like ZEPBOUND%, state MS, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MS", "product_name": "product_name like ZEPBOUND%, state MS, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Zepbound, MS
State Drug Utilization Data 2021, Datastore query result, product_name like ZEPBOUND%, state MS, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MS", "product_name": "product_name like ZEPBOUND%, state MS, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Mounjaro, MS
State Drug Utilization Data 2026, Datastore query result, product_name like MOUNJARO%, state MS, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "MS", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "MOUNJARO 1", "suppression_used": "false", "number_of_prescriptions": "160"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Mounjaro, MS
State Drug Utilization Data 2025, Datastore query result, product_name like MOUNJARO%, state MS, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MS", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO 1", "suppression_used": "false", "number_of_prescriptions": "133"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Mounjaro, MS
State Drug Utilization Data 2024, Datastore query result, product_name like MOUNJARO%, state MS, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MS", "year": "2024", "quarter": "2", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "117"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Mounjaro, MS
State Drug Utilization Data 2023, Datastore query result, product_name like MOUNJARO%, state MS, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MS", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO 1", "suppression_used": "false", "number_of_prescriptions": "71"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Mounjaro, MS
State Drug Utilization Data 2022, Datastore query result, product_name like MOUNJARO%, state MS, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MS", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "18"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Mounjaro, MS
State Drug Utilization Data 2021, Datastore query result, product_name like MOUNJARO%, state MS, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MS", "product_name": "product_name like MOUNJARO%, state MS, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Wegovy, MS
State Drug Utilization Data 2026, Datastore query result, product_name like WEGOVY%, state MS, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "MS", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "WEGOVY 2.4", "suppression_used": "false", "number_of_prescriptions": "3284"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Wegovy, MS
State Drug Utilization Data 2025, Datastore query result, product_name like WEGOVY%, state MS, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MS", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY 2.4", "suppression_used": "false", "number_of_prescriptions": "3238"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Wegovy, MS
State Drug Utilization Data 2024, Datastore query result, product_name like WEGOVY%, state MS, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MS", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY 2.4", "suppression_used": "false", "number_of_prescriptions": "1275"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Wegovy, MS
State Drug Utilization Data 2023, Datastore query result, product_name like WEGOVY%, state MS, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MS", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY 0.2", "suppression_used": "false", "number_of_prescriptions": "168"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Wegovy, MS
State Drug Utilization Data 2022, Datastore query result, product_name like WEGOVY%, state MS, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MS", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY ", "suppression_used": "false", "number_of_prescriptions": "12"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Wegovy, MS
State Drug Utilization Data 2021, Datastore query result, product_name like WEGOVY%, state MS, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MS", "product_name": "product_name like WEGOVY%, state MS, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Ozempic, MS
State Drug Utilization Data 2026, Datastore query result, product_name like OZEMPIC%, state MS, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "MS", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "OZEMPIC 2M", "suppression_used": "false", "number_of_prescriptions": "301"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Ozempic, MS
State Drug Utilization Data 2025, Datastore query result, product_name like OZEMPIC%, state MS, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MS", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC 2M", "suppression_used": "false", "number_of_prescriptions": "315"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Ozempic, MS
State Drug Utilization Data 2024, Datastore query result, product_name like OZEMPIC%, state MS, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MS", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC 2M", "suppression_used": "false", "number_of_prescriptions": "290"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Ozempic, MS
State Drug Utilization Data 2023, Datastore query result, product_name like OZEMPIC%, state MS, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MS", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC 1M", "suppression_used": "false", "number_of_prescriptions": "238"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Ozempic, MS
State Drug Utilization Data 2022, Datastore query result, product_name like OZEMPIC%, state MS, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MS", "year": "2022", "quarter": "3", "utilization_type": "MCOU", "product_name": "OZEMPIC 1M", "suppression_used": "false", "number_of_prescriptions": "229"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Ozempic, MS
State Drug Utilization Data 2021, Datastore query result, product_name like OZEMPIC%, state MS, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MS", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC 1 ", "suppression_used": "false", "number_of_prescriptions": "159"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Rybelsus, MS
State Drug Utilization Data 2026, Datastore query result, product_name like RYBELSUS%, state MS, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "MS", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "RYBELSUS 1", "suppression_used": "false", "number_of_prescriptions": "17"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Rybelsus, MS
State Drug Utilization Data 2025, Datastore query result, product_name like RYBELSUS%, state MS, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MS", "year": "2025", "quarter": "1", "utilization_type": "MCOU", "product_name": "RYBELSUS 1", "suppression_used": "false", "number_of_prescriptions": "27"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Rybelsus, MS
State Drug Utilization Data 2024, Datastore query result, product_name like RYBELSUS%, state MS, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MS", "year": "2024", "quarter": "2", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "35"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Rybelsus, MS
State Drug Utilization Data 2023, Datastore query result, product_name like RYBELSUS%, state MS, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MS", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "28"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Rybelsus, MS
State Drug Utilization Data 2022, Datastore query result, product_name like RYBELSUS%, state MS, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MS", "year": "2022", "quarter": "3", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "33"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Rybelsus, MS
State Drug Utilization Data 2021, Datastore query result, product_name like RYBELSUS%, state MS, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MS", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "24"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Saxenda, MS
State Drug Utilization Data 2026, Datastore query result, product_name like SAXENDA%, state MS, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "MS", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "64"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Saxenda, MS
State Drug Utilization Data 2025, Datastore query result, product_name like SAXENDA%, state MS, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MS", "year": "2025", "quarter": "3", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "75"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Saxenda, MS
State Drug Utilization Data 2024, Datastore query result, product_name like SAXENDA%, state MS, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MS", "year": "2024", "quarter": "2", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "70"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Saxenda, MS
State Drug Utilization Data 2023, Datastore query result, product_name like SAXENDA%, state MS, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MS", "year": "2023", "quarter": "3", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "150"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Saxenda, MS
State Drug Utilization Data 2022, Datastore query result, product_name like SAXENDA%, state MS, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MS", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "26"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Saxenda, MS
State Drug Utilization Data 2021, Datastore query result, product_name like SAXENDA%, state MS, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MS", "year": "2021", "quarter": "4", "utilization_type": "FFSU", "product_name": "SAXENDA 18", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Victoza, MS
State Drug Utilization Data 2026, Datastore query result, product_name like VICTOZA%, state MS, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "MS", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "168"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Victoza, MS
State Drug Utilization Data 2025, Datastore query result, product_name like VICTOZA%, state MS, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MS", "year": "2025", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "261"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Victoza, MS
State Drug Utilization Data 2024, Datastore query result, product_name like VICTOZA%, state MS, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MS", "year": "2024", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "854"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Victoza, MS
State Drug Utilization Data 2023, Datastore query result, product_name like VICTOZA%, state MS, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MS", "year": "2023", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "1462"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Victoza, MS
State Drug Utilization Data 2022, Datastore query result, product_name like VICTOZA%, state MS, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MS", "year": "2022", "quarter": "3", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "1510"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Victoza, MS
State Drug Utilization Data 2021, Datastore query result, product_name like VICTOZA%, state MS, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MS", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "1336"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Liraglutid, MS
State Drug Utilization Data 2026, Datastore query result, product_name like LIRAGLUTID%, state MS, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "MS", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "16"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Liraglutid, MS
State Drug Utilization Data 2025, Datastore query result, product_name like LIRAGLUTID%, state MS, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MS", "year": "2025", "quarter": "3", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "47"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Liraglutid, MS
State Drug Utilization Data 2024, Datastore query result, product_name like LIRAGLUTID%, state MS, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MS", "year": "2024", "quarter": "3", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "50"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Liraglutid, MS
State Drug Utilization Data 2023, Datastore query result, product_name like LIRAGLUTID%, state MS, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MS", "product_name": "product_name like LIRAGLUTID%, state MS, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Liraglutid, MS
State Drug Utilization Data 2022, Datastore query result, product_name like LIRAGLUTID%, state MS, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MS", "product_name": "product_name like LIRAGLUTID%, state MS, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Liraglutid, MS
State Drug Utilization Data 2021, Datastore query result, product_name like LIRAGLUTID%, state MS, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MS", "product_name": "product_name like LIRAGLUTID%, state MS, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026

How the quoted row is presented, for 39 of these documents

One row of the API response for the query in url, with the fields that do not bear on this fact omitted and the rest left exactly as the API returns them, including the trailing spaces the ten-character product_name field pads with. Open the url to re-read the whole result set and re-sum it.

How the quoted row is presented, for 9 of these documents

The query in url returns an empty result set, which is the evidence. An absence cannot be quoted, so the record states the query and its count instead.

Common questions

Does a paid prescription mean Mississippi Medicaid covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.